A type D retrovirus, simian acquired immune deficiency syndrome (SAIDS) retrovirus serotype 1 (SRV-1), has consistently been associated with SAIDS occurring spontaneously in rhesus monkeys (Macacca mulatta) at the California Primate Research Center (19, 20, 21) . This fatal immunosuppressive disease was experimentally transmitted to rhesus monkeys with tissue culture-derived virus. Animals with terminal disease had a variety of clinical signs of SAIDS, including wasting, chronic diarrhea, noma, disseminated cytomegalovirus infections, and bacterial pneumonia (19, 20, 21, 26) . At the cellular level, a markedly diminished response of peripheral blood mononuclear cells to mitogens, as well as anemia and lymphopenia, was reported (22, 25) . The disease was fatal in about half of the cases (four of nine), although inapparent carriers which are virus positive but apparently free of the disease have also been identified (16) .
New England, Washington, and Oregon Regional Primate Centers have also reported SAIDS outbreaks in their colonies, affecting not only rhesus monkeys (M. mulatta), but also Taiwanese rock macaques (M. cyclopis), crab-eating macaques (M. fiiscicularis), and pigtailed macaques (M. nemestrina) (7, 19, 31) . In each case, it was found that the disease was strongly linked to infection with type D retroviruses. In addition to immune suppression, the animals at the Washington and Oregon Primate Centers, which are infected with a distinct SAIDS retrovirus serogroup (SAIDS retrovirus type 2 [SRV-2]) (19; P. A. Marx, unpublished data), have developed retroperitoneal fibromatosis, an aggressive proliferation of fibrous tissue in the abdominal cavity (10, 31) . The viruses isolated at each of the four centers were shown to be related to Mason-Pfizer monkey virus (MPMV) by competitive radioimmune assays with the gag-derived p27 polypeptide (19, 20, 31) and by nucleic acid hybridizations (2, 7, 31) . However, radioimmune assays done with envelope glyco-protein gp7O revealed that each isolate was distinct from MPMV (1) . Neutralization assays also showed that MPMV, SRV-1, and SRV-2 belong to distinct serogroups (5, 19) .
Since results of transmission studies in rhesus monkeys with type D retroviruses have suggested that some type D viral isolates found at the various primate centers may be less pathogenic than others (17), we have sought to determine if this fatal immunodeficiency disease could be induced with molecularly cloned virus. The first clone of SRV-1 obtained was not infectious (27; M. Bryant, unpublished data), so additional clones were derived and tested for this study. We here report that a full-length molecular clone of SRV-1 was transfected into heterologous cells to produce infectious virus. Inoculation of this molecularly cloned SRV-1 resulted in fatal SAIDS in three of six animals. The other three surviving animals in the study developed a milder form of the disease. In this paper, we describe the molecular cloning, present a brief summary of the DNA sequence of this pathogenic clone, and report the induction of a fatal immunosuppressive disease in rhesus monkeys with the molecularly cloned virus. The complete nucleotide sequence of this pathogenic clone is filed with the National Biomedical Resource Foundation, Washington, D.C.
MATERIALS AND METHODS Molecular cloning of SRV-1. High-molecular-weight DNA of chronically SRV-1-infected ATCC HTB-82 cells, a human rhabdomyosarcoma cell line, was partially digested with restriction endonuclease MboI. Fragments 20 kilobases in length were isolated by sucrose gradient centrifugation and ligated into lambda EMBL3 arms (9), as described by Maniatis et al. (18) . Recombinant bacteriophage (1.5 x 106 PFU) was screened with 32P-labeled cloned MPMV DNA (3, 4) . Four positive clones were plaque purified and restriction mapped by standard protocol (18) .
DNA sequencing. The proviral DNA of clone X GH2 was completely sequenced by using the dideoxy chain terminator method (29) and M13mp subclones as sequencing templates b Titers of SRV-1 are SIU/ml in Raji cells (7). (23, 24) . The subclones contained fragments obtained by partially digesting gel-purified DNA with a combination of restriction enzymes, each of which generates blunt ends.
Other templates were nested sets of deletions on the primer proximal side of larger inserts obtained as described previously (33) . DNA sequence data were analyzed by computer with standard programs (14, 15) . DNA transfection. A GH2 DNA (23 R,g) and linearized pSV2neo (2 R,g) (30) were transfected in 105 exponentially growing D17 canine osteosarcoma cells by the calcium phosphate coprecipitation protocol (11) . At 48 h after transfection, the cells were transferred to medium containing 200 ,ug of G418 per ml (30) . Individual colonies became visible after 7 to 10 days and were cloned out and expanded.
Animals. Six healthy rhesus monkeys 9 to 17 months old were chosen from the SAIDS-free colony at the California Primate Research Center. All were born at the California Primate Research Center and were maintained on standard laboratory monkey chow (Ralston Purina Co.) and water ad libitum. They were confirmed free of SRV-1 antibodies by enzyme-linked immunosorbent assay (19) (Table 1) , and preexisting type D viremia was excluded by cocultivating their peripheral blood mononuclear cells with Raji cells as described elsewhere (14a). The six monkeys were randomly divided into three pairs, and each pair was housed separately in a HEPA-filtered isolator.
Induction of SRV-1 infection and SAIDS. Animals received a single intravenous (i.v.) inoculation of SRV-1 derived from the infectious molecular clone transfected into D17 cells. The criteria used to determine if an inoculated monkey developed SAIDS were as previously published (26) , specifically, that rhesus monkeys diagnosed with SAIDS must have persistent generalized lymphadenopathy and four or more of the following clinical signs: (i) splenomegaly; (ii) weight loss of >10%; (iii) anemia (<30% packed erythrocyte volume); (iv) neutropenia; (v) persistent lymphopenia; (vi) lymphoid depletion; (vii) marrow hyperplasia; (viii) persistent diarrhea unresponsive to appropriate therapy; and (ix) opportunistic infections, such as generalized cytomegalovirus infections, intestinal cryptosporidiosis, esophageal candidiasis, or multiple bacterial infections unresponsive to appropriate therapy. SAIDS-related complex (SRC) is generalized lymphadenopathy and less than four clinical signs of SAIDS.
After i.v. inoculation of molecularly cloned SRV-1, each animal was examined weekly for signs of SAIDS. Sera were collected immediately before inoculation and every 4 weeks thereafter to test for SRV-1 antibody in an enzyme-linked immunosorbent assay. Viremia with SRV-1 was determined by cocultivation of peripheral blood mononuclear cells with Raji cells in a syncytium induction assay (19) . All Raji cell cultures displaying characteristic syncytia were confirmed as type D positive by fixed-cell immunofluorescence with anti-SRV-1 monoclonal antibody against the gp2O envelope polypeptide (19; H. S. Kwang, manuscript in preparation).
RESULTS
Molecular clones of the integrated provirus of SRV-1. SRV-1 isolated from a rhesus monkey with terminal SAIDS was transferred from rhesus kidney cells to heterologous cell line ATCC HTB-82 (a human rhabdomyosarcoma cell line) to avoid difficulties during the molecular cloning of the integrated proviral DNA caused by endogenous rhesus sequences which are related to type D retroviral sequences (6) . Although the cells were transferred for several passages after infection before high-molecular-weight DNA was extracted for cloning, we isolated only four clones from 1.5 x 106 PFU, suggesting that there was still less than one integrated provirus per cell. Restriction mapping (Fig. 1) showed that only one recombinant phage contained a fulllength integrated provirus, based on the fragments common to all clones and compared with the restriction map of MPMV (3) . No The entire sequence of the integrated provirus and a portion of the flanking DNA was determined by the dideoxy chain terminator method on M13mp templates (13, 24, 29) . The genome of the integrated provirus of SRV-1 is 8,168 base pairs long and is flanked by 6-base-pair direct repeats (data not shown), probably representing the host sequences duplicated upon integration. As shown previously for the sequence of the unintegrated provirus (27) , the integrated provirus of SRV-1 contains four large open reading frames, 663, 314, 866, and 605 codons long, encoding the gag, protease, polymerase, and envelope polypeptides, respectively (Fig. 1) . A comparison of the sequence of GH2 with that of the noninfectious molecular clone (27; Marx, unpublished data), derived from an unintegrated provirus (27) , revealed 20 differences, most of which were simple nucleotide exchanges resulting in 10 amino acid changes (Fig. 2) . A cluster of exchanges and small insertions and deletions can be seen in the 5' leader sequence which extends the tRNALYS primer-binding site from 14 nucleotides in the noninfectious clone to 19 nucleotides in the infectious GH2 clone (Fig. 2) .
Transfection and infectivity of clone lambda GH2. To test the biological activity of the full-length clone of SRV-1, we cotransfected X GH2 with pSV2neo into the D17 canine osteosarcoma cell line. We chose this heterologous line, rather than a rhesus cell line, to minimize potential recombination of the cloned provirus with endogenous MPMVrelated sequences present in the genomes of macaques (5 (8, 19) .
Based on results of the Raji syncytium assay (19) (Fig. 2) was inoculated into six juvenile rhesus monkeys ranging in age from 9 to 17 months. Before inoculation, all animals were clinically healthy and seronegative for type D retroviruses ( Table 1) .
The six rhesus monkeys were divided into three separate transmission groups (Table 1 ). In the first experiment, transfected SRV-1 from D17 cells was passaged once in rhesus lung fibroblast cells. Since all of the virus used in our previous transmission studies (20, 21) (27) above and below the line are from the noninfectious (27) months p.i., included generalized lymphadenopathy, splenomegaly, and viremia, all of which persisted until death. At about 9 weeks, it had anemia, diarrhea, weight loss, and fever which also persisted until death. At necropsy, generalized lymphoid depletion, marrow hyperplasia, bacterial septicemia, and interstitial pneumonia were found.
In conclusion, molecularly cloned SRV-1 induced a broad spectrum of disease ranging from transient viremia to fulminant SAIDS (Table 1) identical to previous transmission studies when either plasma (12) or tissue culture medium containing uncloned SRV-1 was used to transmit the disease (20, 21) .
DISCUSSION
We have isolated a molecular clone of the full-length integrated provirus of SRV-1 which produced fatal SAIDS when reinoculated into juvenile rhesus macaques. Clones obtained from unintegrated proviral forms of the same virus isolate which we reported earlier (27) are biologically inactive. Comparison of the two sequences shows only 20 differences at the nucleic acid sequence level, resulting in 10 amino acid exchanges. The high ratio of nonsilent-to-silent exchanges suggests that these two sequences represent two time frames in the evolution of SRV-1 which are not yet separated by selection, which would lower the apparent occurrence of nonsilent mutations. A cluster of deletions or insertions of one nucleotide can be found in the 5' leader sequence extending the tRNALYS primer-binding site from 14 nucleotides found in the unintegrated provirus to a sequence of 19 residues, which is in better agreement with those described for other viruses (32) . It is unclear at this point whether these nucleotide changes are responsible for the difference in the in vitro infectivity of the clones obtained from the integrated and unintegrated proviral forms. It is also possible that the reversal of the circular permutation necessary to restore the natural configuration of the unintegrated provirus was not successful. Further experiments should elucidate this point.
Most significantly, the infection experiments performed with the virus produced by transfection of lambda GH2 unequivocally demonstrate that this type D virus is able to infect macaques and induce a fatal immunosuppressive syndrome. These results represent conclusive proof of the type D retrovirus etiology of SAIDS in rhesus monkeys at the California Primate Research Center. The disease induced by molecularly cloned SRV-1 is identical to that previously observed in experimental transmission studies with either whole blood-, plasma-, or tissue culture-derived SRV-1 obtained from spontaneous cases of SAIDS (12, 20, 21) . With molecularly cloned SRV-1, the entire spectrum of disease from mild signs to fatal SAIDS was observed (Table   1 (Marx, unpublished data) . Recombinants of pathogenic and nonpathogenic clones will be used to find the genetic sequences responsible for immunosuppression in rhesus monkeys.
